Canada· CA-DIN-00050466
METHYLENE BLEU LIQ 1%
A methylthioninium chloride product containing methylene blue, registered in Canada by LABORATOIRE ATLAS INC.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- METHYLENE BLUE
- Manufacturer
- LABORATOIRE ATLAS INC
- Country
- Canada (CA)
- ATC code
- V04CG05
- ATC class
- Methylthioninium chloride
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methylthioninium chloride in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesArthcal 1% METHYLENE BLUEBeijing JUNGE Technology Co., Ltd.
- United KingdomMethylthioninium chloride (methylene blue) 100mg/10ml solution for injection ampoulesMartindale Pharmaceuticals Ltd
- BelgiumLumeblue 25 mgCosmo Technologies
- CzechiaMETHYLTHIONINIUMCHLORID PROVEBLUEPROVEPHARM SAS, Marseille
- IrelandLumeblue 25 mg prolonged-release tabletsAlfasigma S.p.A
- FinlandLumeblueCosmo Technologies Limited
- SwedenMethylthioninium chloride Proveblue 5 mg/ml Injektionsvätska, lösningProvepharm SAS
- NorwayMetibloSterop
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Metiblo
- United Kingdom (Northern Ireland) · Methylthioninium Chloride Phebra Limited
- Iceland · Proveblue
- Italy · Metiltioninio Cloruro Bioindustria L.I.M., Metiltioninio Cloruro Monico
- Liechtenstein · Proveblue
- Norway · Proveblue
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7827be2c-8540-4b06-9cc3-948516198bac GET /v1/drugs/7827be2c-8540-4b06-9cc3-948516198bac?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "00050466",
"form": "LIQUID",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V04CG05",
"schedule": [
"OTC"
],
"drug_code": "68",
"strengths": [
"1 %"
],
"ahfs_class": null,
"substances": [
"METHYLENE BLUE"
],
"product_categorization": null
}See everything about methylthioninium chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.